maropitant has been researched along with glycopyrrolate in 1 studies
Studies (maropitant) | Trials (maropitant) | Recent Studies (post-2010) (maropitant) | Studies (glycopyrrolate) | Trials (glycopyrrolate) | Recent Studies (post-2010) (glycopyrrolate) |
---|---|---|---|---|---|
74 | 36 | 56 | 1,198 | 404 | 522 |
Protein | Taxonomy | maropitant (IC50) | glycopyrrolate (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0005 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0002 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0002 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0001 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Burke, JE; Hess, RS; Silverstein, DC | 1 |
1 trial(s) available for maropitant and glycopyrrolate
Article | Year |
---|---|
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting | 2021 |